MedTech Dive May 28, 2024
From pulsed field ablation devices to Intuitive’s latest da Vinci robot, product launches dominated recent earnings calls.
Product launches for key medtech businesses led earnings calls this season, as new ablation devices and robotic surgery systems hit the market and investors await the upcoming release of an over-the-counter glucose sensor.
Boston Scientific and Medtronic focused on new pulsed field ablation (PFA) systems during their calls, with both companies providing first looks at the performance of the recently launched products to treat atrial fibrillation, a common irregular heart rhythm. Meanwhile, Abbott and Johnson & Johnson provided updates on their PFA systems, which are not yet available in the U.S.
Boston Scientific CEO Mike Mahoney touted the Farapulse PFA system as the...
Today's Sponsors
Today's Sponsor